Novelix Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 5, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	1,117	265	139	73	72	55
Market Cap Growth	1521.73%	90.16%	91.00%	1.24%	31.51%	248.45%
Enterprise Value	1,102	263	114	47	68	32
Last Close Price	56.01	26.61	17.19	9.00	8.89	6.76
PE Ratio	46.74	313.26	1337.29	-	-	-
PS Ratio	0.87	0.86	3.07	3.80	0.81	0.57
PB Ratio	4.36	1.51	1.89	1.01	0.94	0.74
P/TBV Ratio	4.48	1.51	1.89	1.01	0.97	0.80
P/FCF Ratio	-	-	-	-	-	3.50
P/OCF Ratio	-	-	-	-	4.54	3.44
EV/Sales Ratio	0.86	0.86	2.52	2.46	0.76	0.34
EV/EBITDA Ratio	45.48	160.02	149.01	-	-	-
EV/EBIT Ratio	46.21	208.07	297.10	-	-	-
EV/FCF Ratio	-	-	-	-	-	2.07
Debt / Equity Ratio	-	-	-	-	0.02	-
Net Debt / Equity Ratio	-0.06	-0.04	-0.47	-0.44	-0.37	-0.32
Net Debt / EBITDA Ratio	-0.60	-4.12	-45.61	1401.47	7.08	0.67
Net Debt / FCF Ratio	-	0.05	10.16	1.31	13.42	-1.49
Asset Turnover	-	1.78	0.62	0.24	0.97	0.82
Inventory Turnover	-	50.81	10.24	2.12	10.66	11.36
Quick Ratio	-	1.96	373.65	60.39	4.98	1.92
Current Ratio	-	2.79	407.44	68.83	6.38	3.37
Return on Equity (ROE)	-	0.68%	0.14%	-0.81%	-26.95%	-40.70%
Return on Assets (ROA)	-	0.46%	0.33%	-0.46%	-3.29%	-19.64%
Return on Invested Capital (ROIC)	7.48%	0.84%	0.48%	-1.32%	-9.60%	-46.53%
Return on Capital Employed (ROCE)	-	0.70%	0.50%	-0.80%	-6.20%	-49.50%
Earnings Yield	1.62%	0.32%	0.07%	-0.82%	-28.15%	-68.74%
FCF Yield	-	-52.09%	-2.47%	-33.05%	-2.94%	28.55%
Buyback Yield / Dilution	-63.39%	9.80%	-28.54%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.